1. MARKETS
  2. SECTOR : PHARMA & BIOTECH
  3. INDUSTRY : MAJOR PHARMACEUTICALS
  4. MAZE THERAPEUTICS INC.
Maze Therapeutics Inc. XNAS: MAZE
15.40 0.36 (2.39%)
81,168
XNAS Volume

XNAS 05 Sep, 2025 10:57 AM (EDT)



Insider Trading disclosures for Maze Therapeutics Inc.

The latest disclosure was made by Neil Exter in Maze Therapeutics Inc. where a trade of 16,000 Stock Option (Right to Buy) done was reported to US exchanges on Aug. 17, 2025.

Insider trading is the trading of a company’s securities by individuals with access to confidential or material non-public information about the company. A company is required to report trading by corporate officers, directors, or other company members with significant access to privileged information to the Securities and Exchange Commission (SEC).

Client Name Client Category Action Reported to Exchange Quantity Post Transaction Holding Traded % Avg. Price Value Security Type
Neil Exter Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 17 Aug 2025 16,000 16,000 - - Stock Option (Right to Buy)
Charles J. Homcy Director 03 Feb 2025 72,727 0 - - Series B Preferred Stock
Jonathan E. Lim Director 03 Feb 2025 37,724 37,724 - - Common Stock
Jonathan E. Lim Director 03 Feb 2025 363,703 0 - - Series A Preferred Stock
Jonathan E. Lim Director 03 Feb 2025 2,231,381 0 - - Series B Preferred Stock
Jonathan E. Lim Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 03 Feb 2025 5,704 5,704 - - Stock Option (Right to Buy)
Jonathan E. Lim Director Sale or transfer of securities back to the company at price $ 0.00 per share. 03 Feb 2025 5,704 0 - - Stock Option (Right to Buy)
Jonathan E. Lim Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 03 Feb 2025 9,086 9,086 - - Stock Option (Right to Buy)
Jonathan E. Lim Director 03 Feb 2025 270,232 307,956 - - Common Stock
Charles J. Homcy Director 03 Feb 2025 20,717 58,047 - - Common Stock
Charles J. Homcy Director 03 Feb 2025 7,422 7,422 - - Common Stock
Charles J. Homcy Director 03 Feb 2025 8,807 37,330 - - Common Stock
Charles J. Homcy Director 03 Feb 2025 169,405 0 - - Series C Preferred Stock
Charles J. Homcy Director 03 Feb 2025 71,564 0 - - Series D-1 Preferred Stock
Charles J. Homcy Director 03 Feb 2025 71,564 7,422 - - Series D-1 Preferred Stock
Charles J. Homcy Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 03 Feb 2025 80,385 80,385 - - Stock Option (Right to Buy)
Charles J. Homcy Director Sale or transfer of securities back to the company at price $ 0.00 per share. 03 Feb 2025 80,385 0 - - Stock Option (Right to Buy)
Charles J. Homcy Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 03 Feb 2025 5,704 5,704 - - Stock Option (Right to Buy)
Charles J. Homcy Director Sale or transfer of securities back to the company at price $ 0.00 per share. 03 Feb 2025 5,704 0 - - Stock Option (Right to Buy)
Charles J. Homcy Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 03 Feb 2025 46,675 46,675 - - Stock Option (Right to Buy)
Charles J. Homcy Director Sale or transfer of securities back to the company at price $ 0.00 per share. 03 Feb 2025 46,675 0 - - Stock Option (Right to Buy)
Charles J. Homcy Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 03 Feb 2025 45,638 45,638 - - Stock Option (Right to Buy)
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc  
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges
View All The Insider Trades disclosures